Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women

Clinical Pharmacokinetics

Volumn 41, Issue 13, 2002, Pages 1105-1113

  Lu, J ^a,b   Pfister, M ^a,c   Ferrari, P ^c   Chen, G ^b   Sheiner, L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JINLING HOSPITAL   (China)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; MAGNESIUM SULFATE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; COMPARTMENT MODEL; CONCENTRATION RESPONSE; DIASTOLIC BLOOD PRESSURE; DRUG CLEARANCE; DRUG EFFECT; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; SIMULATION; SYSTOLIC BLOOD PRESSURE;

EID: 0036032584     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200241130-00007     Document Type: Article

References (26)

1. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and Caribbean. Br J Obstet Gynaecol 1992; 99: 547-53
2. Prichard JA. Management of pre-eclampsia and eclampsia. Kidney Int 1980; 18: 259-66
3. The Collaborative Eclampsia Trial Group. Which anticonvulsant for women with eclampsia?: Evidence from the collaborative eclampsia trial. Lancet 1995; 345: 1455-63
4. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 2051-5
5. Lu JF, Nightingale CH. Magnesium sulfate in eclampsia and pre-eclampsia: Pharmacokinetic principles. Clin Pharmacokinet 2000; 38: 305-14
6. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998; 92: 883-9
7. Widman L, Wester P, Stegmayr B, et al. The dose-dependent reduction in blood pressure through administration of magnesium: A double blind placebo controlled cross-over study. Am J Hypertens 1993; 6: 41-5
8. Cotton DB, Gonik B, Dorman KF. Cardiovascular alterations in severe pregnancy-induced hypertension: Acute effects of intravenous magnesium sulfate. Am J Obstet Gynecol 1984; 149: 162-5
9. Rudnicki M, Frohlich A, Fischer-Ramussen W, et al. The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension. Acta Obstet Gynecol Scand 1991; 70: 445-50
10. Scardo JA, Hogg BB, Newman RB. Favorable hemodynamic effect of magnesium sulfate in preeclampsia. Am J Obstret Gynecol 1995; 173: 1249-53
11. Rudnicki M, Frohlich A, Pilsgaard K, et al. Comparison of magnesium and methyldopa for the control of blood pressure in pregnancies complicated with hypertension. Gynecol Obstet Invest 2000; 49: 231-5
12. Holford N, Sheiner L. Understanding the dose-effect relationship: Clinical applications of pharmacokinetic/pharmacodynamic models. Clin Pharmacokinet 1981; 6: 429-53
13. Sheiner LB, Steimer JL. Pharmacokinetic/pharmacodynamic modeling in drug development. Annu Rev Pharmacol Toxicol 2000; 40: 67-96
14. Australasian Society for the Study of Hypertension in Pregnancy. Consensus statement: Management of hypertension in pregnancy: Executive summary. Med J Aust 1993; 58: 700-2
15. Beal SL, Sheiner LB. NONMEM User's Guide. San Francisco: University of California, 1989-1998
16. Hempel G, Karlsson MO, de Alwis DP, et al. Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements. Clin Pharmacol Ther 1998; 64 (6): 622-35
17. Wade JR, Sambol NC. Felodipine population dose-response and concentration-response relationships in patients with essential hypertension. Clin Pharmacol Ther 1995; 57 (5): 569-81
18. Hermida RC, Ayala DE, Mojon A, et al. Blood pressure patterns in normal pregnancy, gestational hypertension, and preeclampsia. Hypertension 2000; 36: 149-58
19. Cox DR, Hinkley DV. Theoretical Statistics. London: Chapman & Hall, 1974
20. Sibai BM, Lipshitz J, Anderson GD, et al. Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia. Obstet Gynecol 1981; 57: 199-201
21. Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 1984; 150: 728-33
22. Idama TO, Lindow SW. Magnesium sulphate: A review of clinical pharmacology applied to obstetrics. Br J Obstet Gynaecol 1998; 105: 260-8
23. Peiker G, Muller B, Erdmann M, et al. The pharmacokinetics of magnesium sulfate in pregnant women with threatened abortion and fetal retardation. Pharmazie 1987; 42: 531-2
24. Chen G, Li Q-N, Guo N. Studies on the pharmacokinetics and pharmacodynamics of MgSO4 in the treatment of pregnancy-induced hypertension [abstract]. Chin J Clin Pharmacol 1991; 7: 11
25. Chuan FS, Charles BG, Boyle RK, et al. Population pharmacokinetics of magnesium in preeclampsia. Am J Obstet Gynecol 2001; 185: 593-9
26. Lee MI, Todd HM, Bowe A. The effect of magnesium infusion on blood pressure and vascular responsiveness during pregnancy. Am J Obstet Gynecol 1984; 149: 705-8